Citations

Clear

861 citation(s) found for "Sd, Wexner".

Activation of a Latent Epitope Causing Differential Binding of Antineutrophil Cytoplasmic Antibodies to Proteinase 3
Moura, Marta Casal , Thompson, Gwen , Nelson, Darlene R. , Fussner, Lynn A. , Hummel, Amber M., Jenne, Dieter E. , Emerling, Daniel , Kallenberg, Cees G. M., Langford, Carol A. , McCune, W. Joseph, Clair, E. William St. , Ytterberg, Steven R. , Stone, John H. , Robinson, William H. , Casal Moura, Marta , Thompson, Gwen E, Merkel, Peter A , Monach, Paul A , Spiera, Robert F , Stone, John H , Robinson, William H , Fervenza, Fernando C. , Merkel, Peter A. , Monach, Paul A. , Seo, Philip , Spiera, Robert , Specks, Ulrich

Mayo Clinic

Arthritis & Rheumatology | December 14, 2022 | Volume: 75 | Issue: 5 | Pages: 748-759

10.1002/art.42418 | PMID 36515151 Get It

Objective Proteinase 3 (PR3) is the major antigen for antineutrophil cytoplasmic antibodies (ANCAs) in the systemic autoimmune vasculitis, granulomatosis with polyangiitis (GPA). PR3‐targeting ANCAs (PR3‐ANCAs) recognize different epitopes on PR3. This study was undertaken to study the effect of mutations on PR3 antigenicity. Methods The recombinant PR3 variants, iPR3 (clinically used to detect PR3‐ANCAs) and iHm5 (containing 3 point mutations in epitopes 1 and 5 generated for epitope mapping studies) immunoassays and serum samples from patients enrolled in ANCA‐associated vasculitis (AAV) trials were used to screen for differential PR3‐ANCA binding. A patient‐derived monoclonal ANCA 518 (moANCA518) that selectively binds to iHm5 within the mutation‐free epitope 3 and is distant from the point mutations of iHm5 was used as a gauge for remote epitope activation. Selective binding was determined using inhibition experiments. Results Rather than reduced binding of PR3‐ANCAs to iHm5, we found substantially increased binding of the majority of PR3‐ANCAs to iHm5 compared to iPR3. This differential binding of PR3‐ANCA to iHm5 is similar to the selective moANCA518 binding to iHm5. Binding of iPR3 to monoclonal antibody MCPR3‐2 also induced recognition by moANCA518. Conclusion The preferential binding of PR3‐ANCAs from patients, such as the selective binding of moANCA518 to iHm5, is conferred by increased antigenicity of epitope 3 on iHm5. This can also be induced on iPR3 when captured by monoclonal antibody MCPR2. This previously unrecognized characteristic of PR3‐ANCA interactions with its target antigen has implications for studying antibody‐mediated autoimmune diseases, understanding variable performance characteristics of immunoassays, and design of potential novel treatment approaches. image
Stereotactic Radiosurgery for Intraventricular Metastases: A Multicenter Study
Mantziaris, Georgios , Pikis, Stylianos , Xu, Zhiyuan , Mullen, Reed, Bernstein, Kenneth , Wei, Zhishuo , Niranjan, Ajay , Lunsford, L. Dade , May, Jaromír , Lee, Cheng-chia, Coupé, François-Louis, Mathieu, David , Sheehan, Kimball , Sheehan, Darrah, Perlow, Haley K. , Peker, Selçuk , Samancı, Yavuz , Peterson, Jennifer , Shepard, Matthew J., Elhamdani, Shahed, Wegner, Rodney E. , Hernández, Wenceslao, Warnick, Ronald E. , Sheehan, Jason P. , Mathieu, David , Mantziaris, Georgios , Perlow, Haley K , Alzate, Juan Diego , Kondziolka, Douglas , Liščák, Roman , Yang, Huai‐Che , Palmer, Joshua D. , Trifiletti, Daniel M. , Elhamdani, Shahed, Speckter, Herwin

Mayo Clinic

Neurosurgery | December 13, 2022 | Volume: 92 | Issue: 3 | Pages: 565-573

10.1227/neu.0000000000002248 | PMID 36512817 Get It

BACKGROUND: Intraventricular metastases (IVMs) are uncommon, and their optimal management remains debatable. OBJECTIVE: To define the safety and efficacy of stereotactic radiosurgery (SRS) in the treatment of IVMs. METHODS: This retrospective, multicenter study included patients managed with SRS for IVMs. SRS-induced adverse events, local tumor or intracranial progression, and the frequency of new-onset hydrocephalus or leptomeningeal spread were documented. Analyses of variables related to patient neuroimaging or clinical outcomes were also performed. RESULTS: The cohort included 160 patients from 11 centers who underwent SRS for treatment of 1045 intracranial metastases, of which 196 were IVMs. The median survival from SRS was 10 months. Of the 154 patients and 190 IVMs with imaging follow-up, 94 patients (61%) experienced distant intracranial disease progression and 16 IVMs (8.4%) progressed locally. The 12- and 24-month local IVM control rates were 91.4% and 86.1%, respectively. Sixteen (10%) and 27 (17.5%) patients developed hydrocephalus and leptomeningeal dissemination post-SRS, respectively. Adverse radiation effects were documented in 24 patients (15%). Eleven patients (6.9%) died because of intracranial disease progression. CONCLUSION: SRS is an effective treatment option for IVMs, with a local IVM control rate comparable with SRS for parenchymal brain metastases. Leptomeningeal spread and hydrocephalus in patients with IVM occur in a minority of patients, but these patients warrant careful follow-up to detect these changes.
Association between Tumor Microbiome and Hypoxia across Anatomic Subsites of Head and Neck Cancers
Dhakal, Aastha , Upadhyay, Rituraj , Wheeler, Caroline E. , Karivedu, Vidhya , Gamez, Mauricio E. , Valentin, Sasha, Vanputten, Meade, Bhateja, Priyanka, Bonomi, Marcelo , Konieczkowski, David J. , Baliga, Sujith , Mitchell, Darrion , Grecula, J.C., Blakaj, Dukagjin , Jhawar, Sachin R. , Spakowicz, Daniel , Wheeler, Caroline , Bhateja, Priyanka , Bonomi, Marcelo , Mitchell, Darrion L , Jhawar, Sachin R , Spakowicz, Daniel , Hoyd, Rebecca , VanPutten, Meade, Denko, Nicholas C.

Mayo Clinic

International Journal of Molecular Sciences | December 8, 2022 | Volume: 23 | Issue: 24 | Pages: 15531

10.3390/ijms232415531 | PMID 36555172 Get It

Purpose/Objective(s): Microbiome has been shown to affect tumorigenesis by promoting inflammation. However, the association between the upper aerodigestive microbiome and head and neck squamous cell carcinoma (HNSCC) is not well established. Hypoxia is a modifiable factor associated with poor radiation response. Our study analyzed the HNSCC tumor samples from The Cancer Genome Atlas (TCGA) to investigate the relationship between different HNSCC tumor subsites, hypoxia, and local tumor microbiome composition. Results: A total of 357 patients were included [Oral cavity (OC) = 226, Oropharynx (OPx) = 53, and Larynx/Hypopharynx (LHPx) = 78], of which 12.8%, 71.7%, and 10.3%, respectively, were HPV positive. The mean (SD) hypoxia scores were 30.18 (11.10), 24.31 (14.13), and 29.53 (12.61) in OC, OPx, and LHPx tumors, respectively, with higher values indicating greater hypoxia. The hypoxia score was significantly higher for OC tumors compared to OPx (p = 0.044) and LHPx (p = 0.002). There was no significant correlation between hypoxia and HPV status. Pseudomonas sp. in OC, Actinomyces sp. and Sulfurimonas sp. in OPx, and Filifactor, Pseudomonas and Actinomyces sp. in LHPx had the strongest association with the hypoxia score. Materials/Methods: Tumor RNAseq samples from TCGA were processed, and the R package “tmesig” was used to calculate gene expression signature, including the Buffa hypoxia (BH) score, a validated hypoxia signature using 52 hypoxia-regulated genes. Microbe relative abundances were modeled with primary tumor location and a high vs. low tertile BH score applying a gamma-distributed generalized linear regression using the “stats” package in R, with adjusted p-value < 0.05 considered significant. Conclusions: In our study, oral cavity tumors were found to be more hypoxic compared to other head and neck subsites, which could potentially contribute to their radiation resistance. For each subsite, distinct microbial populations were over-represented in hypoxic tumors in a subsite-specific manner. Further studies focusing on an association between microbiome, hypoxia, and patient outcomes are warranted.
Influence of insurance status on the postoperative outcomes of cytoreductive surgery and HIPEC
Kubi, Boateng , Nudotor, Richard , Fackche, Nadege , Rowe, Julian , Cloyd, Jordan M. , Grotz, Travis E. , Dineen, Seán , Veerapong, Jula , Baumgartner, Joel , Dhar, Vikrom K. , Lambert, Laura , Abbott, Daniel E. , Pokrzywa, Courtney , Raoof, Mustafa , Lee, Byrne , Zaidi, Mohammad Y. , Grotz, Travis E , Dineen, Sean P , Clarke, Callisia N , Patel, Sameer H , Dhar, Vikrom , Abbott, Daniel E , Raoof, Mustafa , Zaidi, Mohammad Y , Maithel, Shishir K , Johnston, Fabian M , Ahmed, Ahmed , Fournier, Keith F. , Clarke, Callisia N. , Greer, Jonathan B.

Mayo Clinic

Journal of Surgical Oncology | December 5, 2022 | Volume: 127 | Issue: 4 | Pages: 706-715

10.1002/jso.27147 | PMID 36468401 Get It

AbstractBackgroundCytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) is increasingly performed for peritoneal surface malignancies but remains associated with significant morbidity. Scant research is available regarding the impact of insurance status on postoperative outcomes.MethodsPatients undergoing CRS/HIPEC between 2000 and 2017 at 12 participating sites in the US HIPEC Collaborative were identified. Univariate and multivariate analyses were used to compare the baseline characteristics, operative variables, and postoperative outcomes of patients with government, private, or no insurance.ResultsAmong 2268 patients, 699 (30.8%) had government insurance, 1453 (64.0%) had private, and 116 (5.1%) were uninsured. Patients with government insurance were older, more likely to be non‐white, and comorbid (p < 0.05). Patients with government (OR: 2.25, CI: 1.50−3.36, p < 0.001) and private (OR: 1.69, CI: 1.15−2.49, p = 0.008) insurance had an increased risk of complications on univariate analysis. There was no independent relationship on multivariate analysis. An American Society of Anesthesiologists score of 3 or 4, peritoneal carcinomatosis index score >15, completeness of cytoreduction score >1, and nonhome discharge were factors independently associated with a postoperative complication.ConclusionWhile there were differences in postoperative outcomes between the three insurance groups on univariate analysis, there was no independent association between insurance status and postoperative complications after CRS/HIPEC.
Killian Jamieson Diverticulum, the Great Mimicker: A Case Series and Contemporary Review
Howell, Rebecca J. , Tang, Alice L. , Allen, Jacqui , Altaye, Mekibib , Bayan, Semirra L. , Belafsky, Peter C. , Cervenka, Brian , deSilva, Brad W. , Dion, Gregory R. , Ekbom, Dale C. , Friedman, Aaron D. , Fritz, Mark A. , Giliberto, John Paul , Harmon, Jeffrey , Kasperbauer, Jan L. , Khosla, Sid , Kim, Brandon , Kuhn, Maggie A. , Madden, Lyndsay L. , Matrka, Laura , Mayerhoff, Ross , Piraka, Cyrus , Rosen, Clark A. , Wahab, Shaun A. , Wilson, Keith , Wright, Stephen C. , Young, VyVy N. , Yuen, Sonia , Postma, Gregory N. , Howell, Rebecca , Bayan, Semirra, Belafsky, Peter , deSilva, Brad , Dion, Greg , Ekbom, Dale , Giliberto, John Paul , Kasperbauer, Jan , Kuhn, Maggie , Matrka, Laura , Mayerhoff, Ross , Rosen, Clark , Tabangin, Meredith , Young, Vyvy , Yuen, Sonia , Bayan, Semirra , Amin, Milan R , Guardiani, Elizabeth , Kwak, Paul E. , Ma, Yue , Tabangin, Meredith E. , Wilson, Keith, Wright, S. Carter

Mayo Clinic

The Laryngoscope | December 1, 2022 | Volume: 133 | Issue: 9 | Pages: 2110-2115

10.1002/lary.30508 | PMID 36453465 Get It

ObjectiveTo assess barium esophagram (BAS) as a diagnostic marker for patients with Killian Jamieson diverticula (KJD).MethodsProspective, multicenter cohort study of individuals enrolled in the Prospective OUtcomes of Cricopharyngeus Hypertonicity (POUCH) Collaborative. Patient demographics, comorbidities, radiographic imaging reports, laryngoscopy findings, patient‐reported outcome measures (PROM), and operative reporting were abstracted from a REDCap database and summarized using means, medians, percentages, frequencies. Paired t‐tests and Wilcoxon Signed Rank test were used to test pre‐ to post‐operative differences in RSI, EAT‐10, and VHI‐10 scores. Diagnostic test evaluation including sensitivity, specificity, positive, and negative predictive value with 95% confidence intervals were calculated comparing BAS findings to operative report.ResultsA total of 287 persons were enrolled; 13 (4%) patients were identified with confirmed KJD on operative reports. 100% underwent open transcervical excision. BAS has a 46.2% (95% confidence interval [CI]: 23.2, 70.9) sensitivity and 97.8% (95% CI: 95.3, 99.0) specificity in detecting a KJD and 50% (95% CI: 25.4, 74.6) positive predictive value but 97.4% (95%CI: 94.8, 98.7) negative predictive value. Preoperatively, patients reported mean (SD) RSI and EAT‐10 of 19.4 (9) and 8.3 (7.5) accordingly. Postoperatively, patients reported mean (SD) RSI and EAT‐10 as 5.4 (6.2) and 2.3 (3.3). Both changes in RSI and EAT‐10 were statistically significant (p = 0.008, p = 0.03).ConclusionKJD are rare and represent <5% of hypopharyngeal diverticula undergoing surgical intervention. Open transcervical surgery significantly improves symptoms of dysphagia. BAS has high specificity but low sensitivity in detecting KJD.Level of Evidence4 Laryngoscope, 133:2110–2115, 2023
Hiding in Plain Sight
Naser, Jwan A. , Fogwe, Delvise T. , Ho, Matthew , Shah, Aditya , Fogwe, Delvise, Corsini Campioli, Cristina , Naser, Jwan A , Ho, Matthew , Campioli, Cristina Corsini

Mayo Clinic

New England Journal of Medicine | November 30, 2022 | Volume: 387 | Issue: 22 | Pages: 2075-2081

10.1056/nejmcps2205021 | PMID 36449424 Get It

Tumors of the Soft Tissues
Miettinen, Markku , Fetsch, John F., Folpe, Andrew L. , Wakely, Paul E. , Antonescu, Cristina R.

Mayo Clinic

No container title available | November 30, 2022 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.55418/9781933477312 Get It

Advances in Cardiac Electrophysiology
Piccini, Jonathan P. , Russo, Andrea M. , Sharma, Parikshit S. , Kron, Jordana , Tzou, Wendy S. , Sauer, William H. , Park, David , Birgersdotter‐Green, Ulrika , Frankel, David S. , Healey, Jeff S. , Linz, Dominik , Wißner, Erik , Zeitler, Emily P. , Wang, Paul J. , Tzou, Wendy , Park, David S , Hummel, John , Koruth, Jacob , Linz, Dominik , Mittal, Suneet , Nair, Devi G , Nattel, Stanley , Noseworthy, Peter A , Steinberg, Benjamin A , Trayanova, Natalia A , Wan, Elaine Y , Wissner, Erik , Zeitler, Emily P , Wang, Paul J , Healey, Jeffrey S , Hummel, John D. , Noseworthy, Peter A. , Steinberg, Benjamin A. , Trayanova, Natalia A. , Wan, Elaine Y.

Mayo Clinic

Circulation: Arrhythmia and Electrophysiology | November 28, 2022 | Volume: 15 | Issue: 12 | Pages: No page available

10.1161/circep.121.009911 | PMID 36441565 Get It

Despite the global COVID-19 pandemic, during the past 2 years, there have been numerous advances in our understanding of arrhythmia mechanisms and diagnosis and in new therapies. We increased our understanding of risk factors and mechanisms of atrial arrhythmias, the prediction of atrial arrhythmias, response to treatment, and outcomes using machine learning and artificial intelligence. There have been new technologies and techniques for atrial fibrillation ablation, including pulsed field ablation. There have been new randomized trials in atrial fibrillation ablation, giving insight about rhythm control, and long-term outcomes. There have been advances in our understanding of treatment of inherited disorders such as catecholaminergic polymorphic ventricular tachycardia. We have gained new insights into the recurrence of ventricular arrhythmias in the setting of various conditions such as myocarditis and inherited cardiomyopathic disorders. Novel computational approaches may help predict occurrence of ventricular arrhythmias and localize arrhythmias to guide ablation. There are further advances in our understanding of noninvasive radiotherapy. We have increased our understanding of the role of His bundle pacing and left bundle branch area pacing to maintain synchronous ventricular activation. There have also been significant advances in the defibrillators, cardiac resynchronization therapy, remote monitoring, and infection prevention. There have been advances in our understanding of the pathways and mechanisms involved in atrial and ventricular arrhythmogenesis.
A Reduced Pancreatic Polypeptide Response is Associated With New-onset Pancreatogenic Diabetes Versus Type 2 Diabetes
Hart, Phil A. , Kudva, Yogish C. , Yadav, Dhiraj , Andersen, Dana K. , Li, Yisheng , Toledo, Frederico G. S. , Wang, Fuchenchu , Cusi, Kenneth , Park, Walter G. , Saeed, Zeb , Considine, Robert V. , Graham, Sarah C., Rinaudo, Jo Ann, Goodarzi, Mark O. , Cusi, Kenneth , Bellin, Melena D. , Bradley, David , Brand, Randall E. , Fisher, William P. , Mather, Kieren J. , Serrano, José

Mayo Clinic

The Journal of Clinical Endocrinology & Metabolism | November 21, 2022 | Volume: 108 | Issue: 5 | Pages: e120-e128

10.1210/clinem/dgac670 | PMID 36404274 Get It

Abstract Purpose Pancreatogenic diabetes refers to diabetes mellitus (DM) that develops in the setting of a disease of the exocrine pancreas, including pancreatic ductal adenocarcinoma (PDAC) and chronic pancreatitis (CP). We sought to evaluate whether a blunted nutrient response of pancreatic polypeptide (PP) can differentiate these DM subtypes from type 2 DM (T2DM). Methods Subjects with new-onset DM (&lt;3 years’ duration) in the setting of PDAC (PDAC-DM, n = 28), CP (CP-DM, n = 38), or T2DM (n = 99) completed a standardized mixed meal tolerance test, then serum PP concentrations were subsequently measured at a central laboratory. Two-way comparisons of PP concentrations between groups were performed using Wilcoxon rank-sum test and analysis of covariance while adjusting for age, sex, and body mass index. Results The fasting PP concentration was lower in both the PDAC-DM and CP-DM groups than in the T2DM group (P = 0.03 and &lt;0.01, respectively). The fold change in PP at 15 minutes following meal stimulation was significantly lower in the PDAC-DM (median, 1.869) and CP-DM (1.813) groups compared with T2DM (3.283; P &lt; 0.01 for both comparisons). The area under the curve of PP concentration was significantly lower in both the PDAC-DM and CP-DM groups than in T2DM regardless of the interval used for calculation and remained significant after adjustments. Conclusions Fasting PP concentrations and the response to meal stimulation are reduced in new-onset DM associated with PDAC or CP compared with T2DM. These findings support further investigations into the use of PP concentrations to characterize pancreatogenic DM and to understand the pathophysiological role in exocrine pancreatic diseases (NCT03460769).